Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2014 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Minimizing the Risks of Medicine
By Patrick M. Schmidt
Features
Rare Adverse Effects of Human Immunoglobulin Therapy
By
E. Richard Stiehm, MD
Myths and Facts: MRSA
By
Ronale Tucker Rhodes, MS
Autoimmune Diseases: The Growing Impact
By
Amy Scanlin, MS
Proactive Screening for Men’s Health
By
Jim Trageser
Practicing Medicine: A New Quality of Care
By
Show No Author
Supply Chain Safety: Where Are We Now?
By
Trudie Mitschang
Chronic Inflammation: The Cause of Disease?
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
CMS Postpones "Two Midnight" Rule
HHS Awards $150M to Grow Health Center Sites
HHS Awards $55.5M to Strengthen America's Healthcare Workforce
HHS Grants Patients' Access to Test Reports from Labs
Proposed New Insurance Standards for 2015 Enrollment
Reimbursement FAQs
Reimbursement FAQs: Coding Systems and Other Updates
Industry News
Pfizer Buys Rights to New Autoimmune Disease Therapy
Tuberculosis Vaccine Effective as Treatment for MS
ACIP Revises Recommended Adult Immunization Schedule
Single-Dose IVIG Results in Early Improvements in Sepsis Patients
Flu Vaccine May Work Better in Women
People and Places in the News
New Gene May Be an Effective Target for Autoimmune Disease Therapy
Vaccine Update
Study Shows No Evidence Multiple Vaccines Raise Autism Risk
Flu Vaccine Decreases Risk of Premature or Low-Birth-Weight Babies
FDA Grants Orphan Status to Diabetes Reversal Drug
Vaccines May Reduce Risk of Strokes in Children
Discharged Patients Who Skip Antibiotic Likely to Be Rehospitalized
BioFocus
Industry Insight
Surviving Sepsis: It's Time to Put Albumin to the Test
By Keith Berman, MPH, MBA
Patient Profile
Learning to Live with COPD
By Trudie Mitschang
Physician Profile
COPD: 5 Things Every Primary Care Physician Needs to Know
By Show No Author
On the Frontlines of Flu Prevention
By Trudie Mitschang
BioSources
BioResearch
Four-Factor Prothrombin Complex Concentrate Superior to Plasma for Warfarin Reversal Required Prior to Urgent Surgery
IVIG May Improve Left Ventrical Function and Reduce Episodes of Arrhythmia in Adults with Acute Fulminant Myocarditis